Phathom Pharmaceuticals Inc (PHAT)

CapEx to Revenue

0.06%

Quarterly · Period ending:

PHAT logo

PHAT CapEx to Revenue

Latest reported0.06%
PHAT Quarterly CapEx/Revenue (0.00% → 0.06%)
High-resolution chart · PNG

PHAT capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Phathom Pharmaceuticals Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.0592%
0.1046%
0.1997%
0.0545%
0.2456%
0.0631%
0.0169%
0.5259%
0.6281%
2.0921%
69.6481%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.